DNA RNA and Cells

09 Mar 2007 La Jolla Pharmaceutical Announces Positive Interim Antibody Results From Riquent Lupus Phase 3 Trial
07 Mar 2007 ProNAi and Novosom AG Announce Collaboration to Enable Delivery of DNAi-based Cancer Therapeutics
02 Mar 2007 AVI BioPharma Presents Novel HIV Drug Candidate Results
01 Mar 2007 IDM Pharma Announces the Completion of Enrollment in Two Phase II Trials of Uvidem(R) in Melanoma
01 Mar 2007 Amsterdam Molecular Therapeutics BV receives global rights to develop and commercialize AMT-020 for acute intermittent porphyria
24 Feb 2007 Phase 2 Results of Genasense(R) Plus Chemotherapy in Advanced Prostate Cancer Reported at Cancer Conference
21 Feb 2007 Stem Cell Sciences Licenses Neural Stem Cell Technology to Merck & Co., Inc.
20 Feb 2007 Skin graft substitute (ICX-SKN) commences Phase I
15 Feb 2007 Aastrom's U.S. Clinical Investigator to Report Interim Data on Long Bone Fracture Repair Trial
15 Feb 2007 BrainStorm Cell Therapeutics Initiates Stem Cell Safety Study in Primates for Parkinson's Disease
14 Feb 2007 Neuralstem Inc. Cells Survive and Become Neurons in Rats With Spinal Injuries, Study Reports
14 Feb 2007 Osiris Announces Top-Line Interim Results for Stem Cell Trial for Knee Repair
13 Feb 2007 Targeted Genetics Provides Inflammatory Arthritis Clinical Trial Update
09 Feb 2007 Pluristem Announces US FDA Acceptance of its Pre-IND Application to begin Pre-clinical Studies using PLX- I in Hematological Malignancies
07 Feb 2007 Genta Announces the Company Will Appeal FDA Action on New Drug Application of Genasense(R) in Chronic Lymphocytic Leukemia
07 Feb 2007 ViaCell Announces CB001 Phase I Results
06 Feb 2007 Antisense Therapeutics Extends its Drug Discovery and Development Collaboration with Isis Pharmaceuticals
06 Feb 2007 SR Pharma Plc Announces Start of Phase I Trial With Novel RNAi Therapeutic RTP-801i in Age-Related Macular Degeneration (AMD)
03 Feb 2007 Genta Completes Response to EMEA List of Outstanding Issues for Genasense® Marketing Authorization Application in Melanoma
02 Feb 2007 Alnylam Presents Pre-clinical Results from Hypercholesterolemia, Huntington's Disease and Neuropathic Pain Programs at Keystone Symposium on RNAi
30 Jan 2007 LCT to start clinical trial of type 1 diabetes treatment
30 Jan 2007 Advanced Viral Begins Phase II Dermatological Study
26 Jan 2007 Enzon Receives FDA Clearance of HIF-1 alpha Investigational New Drug Application
25 Jan 2007 Introgen Reports that INGN 241 in Combination with Avastin(R) Results in Complete Tumor Regression
23 Jan 2007 iCo Therapeutics Receives FDA Clearance to Initiate Clinical Trial in Diabetic Macular Edema

La Merie Biologics

FREE Weekly News Bulletin

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top